Varinder Kaur

1.1k total citations
41 papers, 270 citations indexed

About

Varinder Kaur is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Varinder Kaur has authored 41 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Varinder Kaur's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (4 papers). Varinder Kaur is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (4 papers). Varinder Kaur collaborates with scholars based in United States, India and Canada. Varinder Kaur's co-authors include Laura F. Hutchins, Yogesh Jethava, Daisy Alapat, Bhagirathbhai Dholaria, Abhishek Deshmukh, Sadip Pant, Gina R. Petroni, Barbara J. Fuhrman, Nikole Varhegyi and Lynn T. Dengel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Varinder Kaur

31 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Varinder Kaur United States 8 70 68 66 63 51 41 270
Klára Gadó Hungary 9 106 1.5× 102 1.5× 26 0.4× 88 1.4× 18 0.4× 30 313
Bruce A. Silver United States 8 34 0.5× 117 1.7× 83 1.3× 75 1.2× 33 0.6× 15 296
Catherine Arendt Belgium 8 61 0.9× 33 0.5× 36 0.5× 28 0.4× 54 1.1× 21 446
Dion Chen United States 8 38 0.5× 52 0.8× 26 0.4× 35 0.6× 13 0.3× 9 357
Deepak M.W. Balak Netherlands 11 31 0.4× 55 0.8× 13 0.2× 49 0.8× 45 0.9× 20 513
S. von Schmiedeberg Germany 9 14 0.2× 38 0.6× 32 0.5× 12 0.2× 68 1.3× 15 271
Hywel Cooper United Kingdom 9 22 0.3× 36 0.5× 37 0.6× 17 0.3× 61 1.2× 15 256
Yusuke Hara Japan 11 137 2.0× 193 2.8× 32 0.5× 78 1.2× 16 0.3× 30 383
Deepak Balak Netherlands 13 58 0.8× 78 1.1× 16 0.2× 40 0.6× 80 1.6× 30 435
María Larrosa-García Spain 3 192 2.7× 135 2.0× 78 1.2× 29 0.5× 14 0.3× 12 290

Countries citing papers authored by Varinder Kaur

Since Specialization
Citations

This map shows the geographic impact of Varinder Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Varinder Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Varinder Kaur more than expected).

Fields of papers citing papers by Varinder Kaur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Varinder Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Varinder Kaur. The network helps show where Varinder Kaur may publish in the future.

Co-authorship network of co-authors of Varinder Kaur

This figure shows the co-authorship network connecting the top 25 collaborators of Varinder Kaur. A scholar is included among the top collaborators of Varinder Kaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Varinder Kaur. Varinder Kaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Reema, et al.. (2025). Immune-related adverse events not associated with survival in advanced or metastatic gastroesophageal cancers. Journal of Chemotherapy. 38(1). 47–53. 1 indexed citations
2.
Kaur, Varinder, et al.. (2024). Single Institution Experience with Immune Checkpoint Inhibitors in Vulvar and Vaginal Melanomas. Obstetrics and Gynecology International. 2024(1). 7327692–7327692. 1 indexed citations
3.
Patel, Reema, Adam Barsouk, Jason Xu, et al.. (2024). Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience. Journal of Oncology Pharmacy Practice. 31(4). 641–648. 1 indexed citations
5.
Kaur, Varinder, et al.. (2024). von Willebrand disease: A guide for the internist. Cleveland Clinic Journal of Medicine. 91(2). 119–127. 4 indexed citations
6.
Mattes, Malcolm D., Henning Willers, Yong Lin, et al.. (2024). CTEP 10492, a phase 1/1b study of the AKT inhibitor ipatasertib with chemoradiation for locally advanced head and neck squamous cell carcinoma.. Journal of Clinical Oncology. 42(16_suppl). TPS6127–TPS6127. 2 indexed citations
7.
Barsouk, Adam, Reema Patel, John S. Wang, et al.. (2024). Impact of immune-related adverse events on survival among patients with head-and-neck squamous cell carcinoma. Immunotherapy. 16(16-17). 1069–1078. 2 indexed citations
8.
Kaur, Varinder, Simon Erridge, Carl Holvey, et al.. (2024). Clinical outcome analysis of patients with multiple sclerosis – Analysis from the UK Medical Cannabis Registry. Multiple Sclerosis and Related Disorders. 87. 105665–105665. 1 indexed citations
9.
Kaur, Varinder, et al.. (2024). The Impact of Domestic Violence on Women’s Mental Health and Well Being. 10(I). 1–10.
10.
Kaur, Varinder, et al.. (2023). Prognostic significance of extra-nodal extension and positive surgical margins in HPV positive oropharyngeal squamous cell carcinoma. American Journal of Otolaryngology. 44(4). 103877–103877. 4 indexed citations
11.
Wang, John, et al.. (2023). Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clinical Journal of Gastroenterology. 16(6). 807–814. 3 indexed citations
13.
Kaur, Varinder, et al.. (2022). To evaluate the resistivity of Klebsiella pneumonia against present antibiogram. International Journal of Health Sciences. 736–743. 1 indexed citations
14.
Kaur, Amritpal, et al.. (2022). Antibiotic resistance pattern of Klebsiella pneumoniae a major problem for society. International Journal of Health Sciences. 4699–4712. 3 indexed citations
15.
Kaur, Varinder, et al.. (2021). A Study to Assess the Prevalence of Anemia and Knowledge Regarding Anemia among Adolescent Girls of Selected Schools of Gurugram, Haryana. Indian Journal of Forensic Medicine & Toxicology. 15(4). 1522–1529.
16.
Kaur, Varinder, et al.. (2021). Image-Guided Versus Blind Corticosteroid Injections in Adults With Shoulder Pain: A Systematic Review and Meta-Analysis. Cureus. 13(8). e17032–e17032. 1 indexed citations
17.
Kaur, Varinder, et al.. (2021). STUDY OF GRIDHRASI AS SCIATICA AND ROLE OF SCIATICA NERVE (GRIDHRASI). International Journal of Ayurveda and Pharma Research. 69–73.
18.
Kumar, Ajay, et al.. (2020). Onosma bracteata Wall. induces G0/G1 arrest and apoptosis in MG-63 human osteosarcoma cells via ROS generation and AKT/GSK3β/cyclin E pathway. Environmental Science and Pollution Research. 28(12). 14983–15004. 14 indexed citations
19.
Kaur, Varinder, et al.. (2017). Ibrutinib in CLL: a focus on adverse events, resistance, and novel approaches beyond ibrutinib. Annals of Hematology. 96(7). 1175–1184. 53 indexed citations
20.
Monzavi‐Karbassi, Behjatolah, Varinder Kaur, Eric R. Siegel, et al.. (2016). Pre-diagnosis blood glucose and prognosis in women with breast cancer. Cancer & Metabolism. 4(1). 7–7. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026